| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | HILL ROM HLDGS INC | 35,000 | 1,349,000 | 0.84% | ||
| 52 | INCYTE CORP | 24,750 | 1,325,000 | 0.83% | ||
| 53 | GLOBUS MED INC | 49,538 | 1,317,000 | 0.82% | ||
| 54 | MEDIVATION INC | 20,000 | 1,287,000 | 0.80% | ||
| 55 | NXSTAGE MED INC COM | 100,000 | 1,274,000 | 0.80% | ||
| 56 | TOWERS WATSON & CO | 11,000 | 1,255,000 | 0.78% | ||
| 57 | Heartware International, Inc. | 13,000 | 1,219,000 | 0.76% | ||
| 58 | CROSS CTRY HEALTHCARE INC COM | 150,000 | 1,211,000 | 0.76% | ||
| 59 | ICON PLC | 25,000 | 1,189,000 | 0.74% | ||
| 60 | INSULET CORPORATION | 25,000 | 1,186,000 | 0.74% | ||
| 61 | ACADIA COMPANY COM | 25,000 | 1,128,000 | 0.70% | ||
| 62 | AMN HEALTHCARE SERVICES INC | 75,106 | 1,032,000 | 0.64% | ||
| 63 | OREXIGEN THERAPEUTICS INC COM | 124,145 | 807,000 | 0.50% | ||
| 64 | PORTOLA PHARMACEUTICALS INC | 30,600 | 793,000 | 0.50% | ||
| 65 | INTERCEPT PHARMACEUTICALS INCORPORATED | 2,000 | 660,000 | 0.41% | ||
| 66 | Sunesis Pharmaceuticals I | 63,087 | 417,000 | 0.26% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001398344-14-002108, filed 2014.04.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
